Fierce Health Technology October 13, 2020
Paige Minemyer

As the coronavirus pandemic hit U.S. shores, CVS Health was in the midst of a major business transformation following its acquisition of Aetna.

CVS closed its $69 billion acquisition of Aetna—one of the largest payers in the country—in late 2018 and was 20 months into integrating when it had to adapt to COVID-19, CEO Larry Merlo said.

Rather than creating a hurdle, Merlo said the pandemic served to underscore CVS’ key strategic goal of making healthcare easier to access through the combined power of its suite of health plans, pharmacy benefit management tools and retail pharmacies.

“The pandemic really became an opportunity to reprioritize elements of that transformation journey,” Merlo said. “It really brought our strategy to life in a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Healthcare System, Insurance, Payer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Retail care, Trends
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
ASHP releases toolkit to protect pharmacy residency programs
STAT+: Pharmalittle: We’re reading about an OptumRx contract, 340B dispute resolution, and more
How can pharma speed time to treatment? Digital tools can help
Personalized Care, Collaboration Key to Navigating Ethics in Oncology Pharmacy

Share This Article